LGD-4033 (Ligandrol) CAS 1165910-22-4

Ligandrol, also known as LGD-4033, is a selective androgen receptor modulator (SARM). Here’s an overview of Ligandrol:

1. Mechanism of Action: Ligandrol works by selectively binding to androgen receptors in the body. It is designed to target these receptors in muscle and bone tissue, which is why it is considered selective compared to traditional anabolic steroids that affect androgen receptors throughout the body.
2. Medical and Research Uses: Ligandrol is primarily investigated for its potential medical applications, such as treating muscle wasting conditions (cachexia) and osteoporosis. It has also been studied for its ability to increase lean muscle mass and improve strength, making it of interest to athletes and bodybuilders as a performance-enhancing drug.
3. Performance Enhancement: Due to its anabolic effects, Ligandrol is sometimes used illicitly in sports and bodybuilding to enhance muscle growth, increase strength, and improve physical performance. Sin embargo, its use for these purposes is prohibited by many sports organizations and considered unethical in competitive sports due to its potential performance-enhancing effects.
4. Safety Considerations: While SARMs like Ligandrol are touted as having fewer side effects compared to traditional anabolic steroids, they are still under investigation for their long-term safety and potential adverse effects. Common side effects reported in studies include testosterone suppression, lipid imbalances, and liver enzyme increases. The full spectrum of potential side effects and risks associated with prolonged use of SARMs is not yet fully understood.
5. Legal Status: The legal status of Ligandrol varies by country. In some regions, SARMs are classified as controlled substances or prohibited for use in dietary supplements and sports due to their potential misuse and health risks.
6. Regulation: Due to concerns over safety and abuse potential, regulatory agencies like the FDA in the United States have issued warnings against the use of SARMs for athletic and bodybuilding purposes without medical supervision.

In conclusion, Ligandrol (LGD-4033) is a selective androgen receptor modulator that shows promise for medical uses but is also associated with risks and regulatory concerns when used for performance enhancement outside of clinical settings. Potential users should carefully consider these factors and consult healthcare professionals for guidance on its use.